Related Experiment Video
Updated: May 7, 2026
06:35
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Racial differences in motor neuron disease
Betul Gundogdu1, Tawfiq Al-Lahham, Fred Kadlubar
1Department of Neurology, University of Arkansas for Medical Sciences Arkansas , USA.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|September 27, 2013
Summary
Black patients with Amyotrophic Lateral Sclerosis (ALS) present earlier and with worse function, despite lower incidence. Further research into genetic factors may reveal disease-modifying genes.
Area of Science:
- Neurology
- Genetics
- Epidemiology
Background:
- Amyotrophic Lateral Sclerosis (ALS), also known as Motor Neuron Disease (MND), affects individuals across racial groups.
- Understanding disparities in ALS/MND presentation and progression is crucial for equitable healthcare.
- Previous data on racial differences in ALS/MND prevalence and clinical features are limited.
Purpose of the Study:
- To compare the clinical characteristics of Black and White patients diagnosed with ALS/MND.
- To analyze differences in disease onset, severity, and survival between racial groups.
- To identify potential genetic factors influencing ALS/MND risk and presentation.
Main Methods:
- Retrospective chart review of ALS/MND patients seen at UAMS clinic (2001-2010).
- Analysis of Arkansas death certificate data for ALS/MND fatalities (1999-2006).
- Comparison of demographic, clinical, and survival data between Black and White patient cohorts.
Main Results:
- Black patients presented with ALS/MND at a significantly earlier average age (52.8 years) compared to White patients (58.1 years).
- Black patients exhibited lower initial ALSFRS-R scores, indicating worse functional status at first visit.
- While overall incidence appeared lower in Black individuals, survival outcomes were similar between racial groups.
Conclusions:
- Black individuals with ALS/MND experience earlier onset and present with more severe functional impairment.
- Despite apparent lower incidence, genetic investigations in Black populations may uncover novel ALS/MND risk and modifying genes.
- Further research is warranted to elucidate the genetic underpinnings of observed racial disparities in ALS/MND.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...